Recent Finacing
Recent Raise
Alys Pharmaceuticals develops immuno-dermatology therapies from combined platforms and assets, advancing 14 programs targeting atopic dermatitis, vitiligo, psoriasis, mastocytosis and oncology supportive dermatologic care.
